IBM vs SUPN · P/E 25, rev $17.16B vs rev $426.8M
International Business Machines (IBM) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
International Business Machines (IBM) is a information technology services company listed on US. It is led by Arvind Krishna.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported IBM revenue for 2026-06-30 was $17.16B. Net income was $2.17B. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
Latest reported SUPN revenue for 2026-06-30 was $426.8M. Net income was -$60.7M. SUPN currently screens at market cap $2.53B.
IBM currently screens at market cap $267.72B and trailing P/E 25.2. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the IBM and SUPN stock pages for the full models.
Not investment advice.